Media Summary: ... way of doing these trials um and that is to use Speaker: Dr. Anna Heath Chair: Dr. Sarina Sahetya Learning Objectives: 1) Bayesian interpretation of In this Episode we talk about: (0:00) Intro (1:09)

Statistical Considerations For Phase Ii Clinical Trials And Adaptive Designs - Detailed Analysis & Overview

... way of doing these trials um and that is to use Speaker: Dr. Anna Heath Chair: Dr. Sarina Sahetya Learning Objectives: 1) Bayesian interpretation of In this Episode we talk about: (0:00) Intro (1:09) This episode delves into the evolution of The purpose of this scientific workshop is to discuss the existing evidence regarding the role of C-peptide in

Photo Gallery

Statistical Considerations for Phase II Clinical Trials and Adaptive Designs
Statistical Considerations for Phase II Trials and Adaptive Designs (中文)
What are adaptive clinical trials?
Adaptive Trial Designs - Introduction for Non-Statisticians
Charles Green:  Bayesian Adaptive Trial Designs
Clinical Trials-All You Need to Know & Statistical Considerations for Phase 1 & 2 Trials
Adaptive Trial Designs - Alex Kaizer @  ERD Conference 6.5.19
How to Design an Adaptive Trial - Lessons Learned...So Far
"Design and Statistical Considerations for Clinical Trials"
Designing an adaptive platform trial a statistical perspective by Dr. Anna Heath
Points to Consider for Clinical Trials and Adaptive Design
Key Multiplicity Issues in Clinical Trials (Part II): Module F
Sponsored
Sponsored
View Detailed Profile
Statistical Considerations for Phase II Clinical Trials and Adaptive Designs

Statistical Considerations for Phase II Clinical Trials and Adaptive Designs

J. Jack Lee, PhD, DDS.

Statistical Considerations for Phase II Trials and Adaptive Designs (中文)

Statistical Considerations for Phase II Trials and Adaptive Designs (中文)

Jack Lee, PhD, DDS.

Sponsored
What are adaptive clinical trials?

What are adaptive clinical trials?

This animation explains what

Adaptive Trial Designs - Introduction for Non-Statisticians

Adaptive Trial Designs - Introduction for Non-Statisticians

Innovations in

Charles Green:  Bayesian Adaptive Trial Designs

Charles Green: Bayesian Adaptive Trial Designs

... way of doing these trials um and that is to use

Sponsored
Clinical Trials-All You Need to Know & Statistical Considerations for Phase 1 & 2 Trials

Clinical Trials-All You Need to Know & Statistical Considerations for Phase 1 & 2 Trials

Part of the

Adaptive Trial Designs - Alex Kaizer @  ERD Conference 6.5.19

Adaptive Trial Designs - Alex Kaizer @ ERD Conference 6.5.19

Adaptive Clinical Trials

How to Design an Adaptive Trial - Lessons Learned...So Far

How to Design an Adaptive Trial - Lessons Learned...So Far

How to

"Design and Statistical Considerations for Clinical Trials"

"Design and Statistical Considerations for Clinical Trials"

CRDEB January Symposium: WVCTSI

Designing an adaptive platform trial a statistical perspective by Dr. Anna Heath

Designing an adaptive platform trial a statistical perspective by Dr. Anna Heath

Speaker: Dr. Anna Heath Chair: Dr. Sarina Sahetya Learning Objectives: 1) Bayesian interpretation of

Points to Consider for Clinical Trials and Adaptive Design

Points to Consider for Clinical Trials and Adaptive Design

This webinar addresses aspects of

Key Multiplicity Issues in Clinical Trials (Part II): Module F

Key Multiplicity Issues in Clinical Trials (Part II): Module F

Module F. General adaptive

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring

Jack Lee, PhD, DDS.

Clinical Research Talks (Episode 7): Adaptive Trial Design & Statistical Interpretation

Clinical Research Talks (Episode 7): Adaptive Trial Design & Statistical Interpretation

In this Episode we talk about: (0:00) Intro (1:09)

Phase II Clinical Trials

Phase II Clinical Trials

Richard L. Schilsky, MD.

Adaptive Clinical Trials: Statistical Innovation in Medicine

Adaptive Clinical Trials: Statistical Innovation in Medicine

This episode delves into the evolution of

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring (中

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring (中

Jack Lee, PhD, DDS.

Statistical Considerations: Phase 1 & 2 Clinical Trials

Statistical Considerations: Phase 1 & 2 Clinical Trials

Part of the

2021 T1D Workshop- Statistical Considerations for Trial Design and Feasibility

2021 T1D Workshop- Statistical Considerations for Trial Design and Feasibility

The purpose of this scientific workshop is to discuss the existing evidence regarding the role of C-peptide in

What Clinicians Should Know About Adaptive Clinical Trials

What Clinicians Should Know About Adaptive Clinical Trials

What Clinicians Should Know About